Series B Investors & VC Firms in Europe
1431 firms in this list, with a median first check of $648K. 338 of them lead rounds. Generated from verified public data and updated continuously.
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
42 people
Shilling VC
LisbonPre-Seed–Series B$108K – $1.1M
23 people
British Business Bank
SheffieldPre-Seed–Late Stage
44 people
3i Group
LondonSeed–Late Stage
31 people
Advent Life Sciences
LondonSeed–Late Stage
29 people
ConsenSys Mesh
ZugPre-Seed–Growth
11 people
Kibo Ventures
MadridSeed–Series B$2.2M – $5.4M
33 people
Acton Capital
MunichSeries A–Growth$5.4M – $10.8M
26 people
NorthEdge
ManchesterSeries B–Late Stage$2.6M – $65M
34 people
Amadeus Capital Partners
LondonPre-Seed–Late Stage$50K – $12.7M
27 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
36 people
Capricorn Venture Partners
LeuvenSeed–Late Stage$270K – $10.8M
30 people
Holland Capital
AmsterdamSeed–Late Stage
45 people
redalpine
ZugSeed–Late Stage$108K – $2.2M
27 people
Supernova Invest
ParisPre-Seed–Late Stage
33 people
P101 Ventures
MilanoPre-Seed–Growth$1.1M – $10.8M
24 people
GP Bullhound
LondonSeed–Growth
49 people
Mercia Ventures
Newcastle upon TyneSeed–Late Stage$130K – $13M
33 people
Axeleo Capital
ParisPre-Seed–Series B$108K – $1.6M
20 people
Kfund
MadridPre-Seed–Growth$108K – $10.8M
25 people
Hoxton Ventures
LondonPre-Seed–Series B$500K – $5M
15 people
Heartfelt Capital
BerlinPre-Seed–Series B$108K – $432K
3 people
Lince Capital
LisbonSeed–Late Stage
36 people
Norrsken VC
StockholmSeed–Growth$1.1M – $3.2M
25 people
Related lists
Investors & VC Firms in North America (13808)Investors & VC Firms in United States (12951)Seed Investors & VC Firms (10929)Series A Investors & VC Firms (8112)Pre-Seed Investors & VC Firms (5907)Seed Investors & VC Firms in North America (5670)Investors & VC Firms in Europe (5511)Seed Investors & VC Firms in United States (5100)Growth Investors & VC Firms (4840)Series A Investors & VC Firms in North America (4569)
Data sourced from public filings and firms' own websites — see our methodology.














































































































